Kidney Int Rep. 2022 Jun;7(6):1424-1427.
Uffing A, Hullekes F, Hesselink DA, Mansur JB, Malvezzi P, de Vries APJ, Seeger H, Manfro RC, Nissaisorakarn P, Wang AX, Reindl-Schwaighofer R, Sanchez-Russo L, Cravedi P, Riella LV , Berger SP
Abstract:
We analyzed a multicenter, international, retrospective case series to determine the clinical course of adult patients with recurrent FSGS treated with long-term apheresis (>6 months).
Download PDF here:
LVR_FSGS recurrence and longterm pheresis KI Reports 2022
Figure 1. Clinical course of patients with post-transplant FSGS actively treated with long-term apheresis (one example).
